AN OPEN-LABEL, MULTICENTER, RANDOMIZED, PHASE II STUDY OF CISPLATIN AND PEMETREXED WITH OR WITHOUT CIXUTUMUMAB (IMC-A12) AS FIRST-LINE THERAPY IN PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER

Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/8209

Title:	AN OPEN-LABEL, MULTICENTER, RANDOMIZED, PHASE II STUDY OF CISPLATIN AND PEMETREXED WITH OR WITHOUT CIXUTUMUMAB (IMC-A12) AS FIRST-LINE THERAPY IN PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER
Authors:	SCAGLIOTTI, Giorgio; CASTRO JR., Gilberto; KIYIK, Murat; RUBEN, Kowalyszyn; DEPPERMANN, Karl-Matthias; ARRIOLA, Edurne; BOSQUEE, Lionel; WILLEY, Richard G.; COSAERT, Jan; RECK, Martin
Citation:	JOURNAL OF THORACIC ONCOLOGY, v.8, suppl.2, p.S601-S601, 2013
Appears in Collections:	Comunicações em Eventos - HC/ICESP Instituto do Câncer do Estado de São Paulo - HC/ICESP Comunicações em Eventos - LIM/24 LIM/24 - Laboratório de Oncologia Experimental

Files in This Item:

There are no files associated with this item.